SECsense Logo

Applied Therapeutics, Inc. 8-K Filing Report - Key Updates for Investors

$APLT
Form 8-K
Filed on: 2025-02-10
Source
Applied Therapeutics, Inc. 8-K Filing Report - Key Updates for Investors

Based on the provided XML section of a financial report, here are the key extracted details:

  1. Company Information:
  • Name: Applied Therapeutics, Inc.
  • CIK: 0001697532
  • State of Incorporation: Delaware (DE)
  • SEC Central Index Key (CIK): 0001697532
  • Address: 545 Fifth Avenue, Suite 1400, New York, NY 10017
  • Phone Number: 212-220-9226
  1. Filing Information:
  • Form Type: 8-K (current report)
  • Filing Date: February 7, 2025
  • Period Covered: February 7, 2025 (the report appears to be for a single day)
  1. Stock Information:
  • Common Stock Ticker: APLT
  • Exchange: NASDAQ
  1. Financial Context:
  • The report is identified as a current report (8-K), which typically indicates significant events that shareholders should be aware of, suggesting that the content may contain important disclosures or updates regarding the company's financial status or operations.

Insights:

  • The filing date indicates a timely disclosure related to company activities or financials, which is crucial for investors and stakeholders.
  • The single-day period of the report might suggest the announcement of a specific event or transaction rather than a comprehensive financial update, which is typical for 8-K filings.
  • The detail about the common stock indicates that the company is publicly traded, and information in the filing may affect its stock performance.

Overall, stakeholders should pay attention to this report for potential implications on the company's operations or financial status as indicated by the 8-K filing.